MRD’s maiden resource positions Mt Ridley as one of the most significant rare earths and critical mineral deposits in ...

Gen Z crypto holdings surge to 23 per cent as young Australians abandon financial experts for AI advice, prompting a warning ...

A seismic shift will slash Australia’s super funds from 75 to just 30 by 2035, as mergers reshape retirement savings.

The market is looking a tad sceptical of US President Trump’s assurances of talks with Iran, with early gains fading swiftly.

Trump flips and markets pile back in ; Oil drops 10% but tension still there ; Miners rebound hard while energy gets hit; The S&P/ASX 200 came out of the gates like it had somethi ...

A UBS analysis shows that five leading healthcare stocks outperformed the S&P/ASX200 index during previous market crises.

Anson Resources' (ASX:ASN) drilling program at the Yellow Cat project aims to confirm mineralisation extensions.

The ASX has slipped into correction territory as metals slump, oil surges and fresh geopolitical tensions rattle early trade ...

Biotech catches a break, with Amplia’s trial results lifting sentiment as psychedelics edge further into the mainstream.

After more than 15 years of setbacks, Mesoblast has finally secured its first FDA approval, and early signs suggest the commercial rollout is gaining traction.

A fresh discovery at Spur has put the Lachlan Fold Belt back in play, with juniors scrambling to prove up the next big hit.

Rhythm Biosciences (ASX:RHY) vision is starting to take flight as Pitt Street values Rhythm at more than double its current ...